Hypoglycemic Drugs Market Is Estimated To Witness High Growth Owing To Rising Diabetes Prevalence The hypoglycemic drugs market is estimated to be valued at US$ 720.72 Mn in 2023 and is expected to exhibit a CAGR of 9.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: The hypoglycemic drugs market involves products used for controlling high blood sugar levels in diabetic patients. The key products in this market...
0 Shares
1036 Views
0 Reviews